米索前列醇片致重度过敏性休克1例分析

doi:10.19803/j.1672-8629.20240201

中国药物警戒 ›› 2024, Vol. 21 ›› Issue (10): 1175-1177.
DOI: 10.19803/j.1672-8629.20240201

米索前列醇片致重度过敏性休克1例分析

姜仁俊¹, 覃树勇^1,*, 王媛¹, 罗穗²

¹重庆市大足区妇幼保健院药剂科,重庆 402360;
²重庆市大足区妇幼保健院妇科,重庆 402360

收稿日期:2024-03-26 出版日期:2024-10-15 发布日期:2024-10-14
通讯作者: ^*覃树勇,男,硕士,副主任药师,医院药学。E-mail: qsy009@163.com
作者简介:姜仁俊,男,本科,主管药师,临床药学。

One case of severe allergic shock caused by misoprostol tablets

JIANG Renjun¹, QIN Shuyong^1,*, WANG Yuan¹, LUO Sui²

¹Department of Pharmacy, Chongqing Dazu District Maternal and Child Health Hospital, Chongqing 402360, China;
²Department of Gynaecology, Chongqing Dazu District Maternal and Child Health Hospital, Chongqing 402360, China

Received:2024-03-26 Online:2024-10-15 Published:2024-10-14

摘要/Abstract

摘要： 目的探讨米索前列醇片致过敏性休克不良反应及其不同给药途径的影响,为临床安全使用提供参考。方法分析1例29岁女性药物流产患者舌下含化米索前列醇片（400μg）后出现过敏性休克并致心搏骤停的可能原因,检索同类文献病例,提出用药建议。结果患者服用米索前列醇片后出现过敏性休克、心搏骤停,分析相关用药和给药时间,考虑疑似为米索前列醇引起的严重药品不良反应。梳理相关文献和病例,提示不同给药途径皆有可能发生不良反应。结论米索前列醇片可能会增加心搏骤停不良反应的风险,临床用药时需警惕,并做好用药教育。

关键词: 米索前列醇, 药物流产, 过敏性休克, 心搏骤停, 前列腺素, 药品不良反应

Abstract: Objective To study one case of allergic shock caused by misoprostol tablets and the effects of different administration routes so as to provide references for safe use. Methods The clinical data of a 29-year-old patient with medical abortion due to 400 μg of misoprostol tablets sublingually was reviewed and the cause of allergic shock leading to cardiac arrest was analyzed. Medications were recommended after related literature was consulted. Results Allergic shock and cardiac arrest occurred in the patient who had received misoprostol tablets sublingually. The analysis of medications time of delivery pointed to severe adverse drug reactions (ADR). By analyzing relevant literature and cases, it was found that ADR might occur through different administration routes. Conclusion Misoprostol tablets may increase the risk of cardiac arrest, so clinical vigilance is required.

Key words: misoprostol, medical abortion, allergic shock, cardiac arrest, prostaglandin, adverse drug reactions

中图分类号:

R984
R994.11

姜仁俊, 覃树勇, 王媛, 罗穗. 米索前列醇片致重度过敏性休克1例分析[J]. 中国药物警戒, 2024, 21(10): 1175-1177.

JIANG Renjun, QIN Shuyong, WANG Yuan, LUO Sui. One case of severe allergic shock caused by misoprostol tablets[J]. Chinese Journal of Pharmacovigilance, 2024, 21(10): 1175-1177.

导出引用管理器 EndNote|Ris|BibTeX

链接本文: https://zgywjj.magtechjournal.com/CN/10.19803/j.1672-8629.20240201

https://zgywjj.magtechjournal.com/CN/Y2024/V21/I10/1175

参考文献

[1] YUAN SS, WANG Y, FENG X, et al.Analysis of 688 cases of adverse drug reaction induced by misoprostol[J]. Chinese Journal of Pharmacovigilance(中国药物警戒), 2021, 18(1): 68-71.
[2] Chinese Medical Association.The Chinese expert consensus on the standardized diagnosis and treatment of missed abortion in the second trimester of pregnancy[J]. Chinese Journal of Practical Gynecology and Obstetrics(中国实用妇科与产科杂志), 2021, 37(9): 928-932.
[3] BARTZ DA, BLUMENTHAL PD. First-trimester pregnancy termination: medication abortion[DB/OL]. (2024-02-21)[2024-05-10]. https://www.uptodate.cn/contents/zh-Hans/first-trimester-pregnancy-termination-medication-abortion.
[4] XIONG GH.Analysis of the clinical effect of Xinmupei combined with misoprostol in the treatment of postpartum hemorrhage[J]. Systems Medicine(系统医学), 2022, 7(1): 159-161.
[5] MAO W, WEN ZF.The prevention of NSAIDs-induced gastroduodenal ulcers-meta analysis[J]. The Journal of Evidence-Based Medicine(循证医学), 2004, 4(4): 220-223.
[6] BARTLEY J, BROWN A, ELTON R, et al.Double-blind randomized trial of mifepristone in combination with vaginal gemeprost or misoprostol for induction of abortion up to 63 days gestation[J]. Hum Reprod, 2001, 16: 2098.
[7] BÉNÉ J, ALARCON P, FAUCON M, et al. Anaphylactic shock after misoprostol in voluntary termination of pregnancy-a case report[J]. Eur J Obstet Gynecol Reprod Biol, 2014, 182: 260-261.
[8] YAN Z, YOU PL, ZHEN WL, et al.Side effect of mifepristone in combination with misoprostol for medical abortion[J]. Chinese Journal of Obstetrics and Gynecology(中华妇产科杂志), 2004, 39(1): 39-42.
[9] Chinese Medical Association.The Chinese expert consensus on the standardized diagnosis and treatment of missed abortion in the second trimester of pregnancy[J]. Chinese Journal of Practical Gynecology and Obstetrics(中国实用妇科与产科杂志), 2021, 37(9): 928.
[10] WHO. Abortion Care Guideline[EB/OL].[2022-03-08]. https://apps.who.int/iris/handle/10665/349316.
[11] ZHAO SD, LU ZP.Factors affecting the evaluation of individual ADR reports[J]. Chinese Journal of Pharmacovigilance(中国药物警戒), 2012, 9(9): 553-555.
[12] XIAO HL, ZHAO HB.A case of anaphylactic shock induced by misoprostol[J]. Herald of Medicine(医药导报), 2001, 20(1): 63.
[13] LI XT, ZHAI SD, WANG Q, et al.Recommendations in guideline for emergency management of anaphylaxis[J]. Adverse Drug Reactions Journal(药物不良反应杂志), 2019, 21(2): 85-91.
[14] WANG JD, WANG HL.Interpretation of European academy of allergy and clinical immunology guideline: anaphylaxis (2021 update)[J]. Chinese Pediatric Emergency Medicine(中国小儿急救医学), 2022, 29(4): 260-265.
[15] XIANG L, WAN WL, QU ZH, et al.Recommendations for the diagnosis and treatment of anaphylaxis in Chinese children[J]. Chinese Journal of Applied Clinical Pediatrics(中华实用儿科临床杂志), 2021, 36(6): 410-415.
[16] LIN GF.Analysis of the effect of different administration routes of misoprostol before induced abortion[J]. Chin J Mod Drug Appl(中国现代药物应用), 2023, 17(10): 111-114.
[17] WANG YH.Effects of mifepristone combined with misoprostol on medical abortion in different administration routes[J]. Electronic Journal of Practical Gynecological Endocrinology(实用妇科内分泌杂志), 2022, 9(23): 41-43.
[18] CAI J, LUO YP.Clinical study on the application of misoprostol in the termination of 8-16 weeks of pregnancy by different administration routes[J]. Medical Innovation of China(中国医学创新), 2018, 15(10): 124-126.
[19] LIN WY.Clinical analysis of misoprostol in induction of abortion in late pregnancy[J]. Journal of Jiangxi University of Chinese Medicine(江西中医药大学学报), 2024, 36(1): 61-63.
[20] ZHONG YF, LIN CX.Evaluation on effect of intravaginal and sublingual administration of misoprostol in outpatient painless abortion[J]. China Prac Med(中国实用医药), 2023, 18(20): 112-115.
[21] GUAN SM, LIN ZR, WU B, et al.1463 adverse reactions of misoprostol tablets in Chongqing city[J]. Journal of Guangdong Medical University(广东医科大学学报), 2022, 40(1): 81-84.
[22] YANG CY, YANG L, ZENG LR, et al.Adverse reactions and safety of misoprostol tablets in different administration routes[J]. Strait Pharmaceutical Journal(海峡医药), 2020, 32(12): 251-252.

米索前列醇片致重度过敏性休克1例分析

One case of severe allergic shock caused by misoprostol tablets

PDF (PC)

可视化

摘要/Abstract

引用本文

使用本文

参考文献

相关文章 15

编辑推荐

Metrics

[1]	孟康康, 夏玉坤. 昂丹司琼制剂安全性风险分析[J]. 中国药物警戒, 2024, 21(9): 1034-1038.
[2]	吴凡, 付林杰, 祝赫, 徐梦艳. 基于美国FAERS和日本JADER数据库的内皮素受体拮抗剂不良事件信号分析[J]. 中国药物警戒, 2024, 21(9): 1056-1063.
[3]	卢靖, 喻珊珊, 童菲, 林卓慧, 宋路瑶. 达格列净片致严重便秘1例分析[J]. 中国药物警戒, 2024, 21(9): 1071-1074.
[4]	刘婷, 曹忠强, 何文佳, 袁秀丽, 陈泽彬, 李学娟. 培门冬酶注射液致急性重症胰腺炎1例分析[J]. 中国药物警戒, 2024, 21(9): 1075-1077.
[5]	魏芬芳, 吴文宇, 李丽敏, 唐碧雨, 吴建茹. 国外药品获益-风险评价方法概述与启示[J]. 中国药物警戒, 2024, 21(8): 900-905.
[6]	王玉玺, 张宗林, 王颖丽, 陈亚飞, 李俊生, 霍艳飞, 谢彦军, 刘文启. 560例脉络舒通丸不良反应/事件报告分析[J]. 中国药物警戒, 2024, 21(8): 921-924.
[7]	赵俊, 董丽, 王洋, 梁瑜, 杨雪, 李恩泽. 艾司洛尔不良反应/事件报告分析[J]. 中国药物警戒, 2024, 21(8): 925-930.
[8]	张乾, 恽渊, 何恋. 1例利培酮致高泌乳素血症患者的药学监护[J]. 中国药物警戒, 2024, 21(8): 936-938.
[9]	晁滢, 张学梅, 张成健, 王贝. 注射用头孢曲松钠致儿童输尿管结石及胆囊结石1例分析[J]. 中国药物警戒, 2024, 21(8): 943-945.
[10]	郭海嬿, 何波, 闫鸿丽, 杨雪婷. 稳心颗粒致持续性呃逆1例分析[J]. 中国药物警戒, 2024, 21(8): 946-948.
[11]	王丹, 董铎, 田春华. 我国药物警戒制度发展历程和思考[J]. 中国药物警戒, 2024, 21(7): 735-740.
[12]	邵波, 郭晓昕. 中药药物警戒回顾与思考[J]. 中国药物警戒, 2024, 21(7): 741-745.
[13]	阿拉腾花, 王振兴, 张晓朦, 世伟, 席成伟, 王聪慧, 王立群, 张冰. 基于药品不良反应监测数据的心脏器官伤害风险信号挖掘分析[J]. 中国药物警戒, 2024, 21(7): 752-758.
[14]	程毅菁, 李涛, 刘军廷, 黄贵民, 钟旭丽, 林爱华, 潘守东, 李龙, 白东升, 占小俊, 刘振江, 任韡, 邰隽. 基于真实世界数据的注射用尖吻蝮蛇血凝酶儿童用药安全性评价[J]. 中国药物警戒, 2024, 21(7): 787-790.
[15]	赵杰, 高明娥, 常虹, 范惠霞. 复方聚乙二醇电解质散致患儿过敏样反应2例分析[J]. 中国药物警戒, 2024, 21(7): 816-818.